Edwards Lifesciences Corporation (EW) financial statements (2021 and earlier)

Company profile

Business Address ONE EDWARDS WAY
IRVINE, CA 92614
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,4031,5179571,3381,2711,2251,439
Cash and cash equivalents1,1831,179714818930718654
Short-term investments219338242519341506785
Restricted cash and investments17      
Receivables515544457422366315288
Inventory, net of allowances, customer advances and progress billings802641607555397340297
Inventory802641607555397340297
Prepaid expense75595461464549
Deferred tax assets    64
Other current assets20816813211711294122
Other undisclosed current assets72568041492937
Total current assets:3,0912,9842,2872,5322,2402,0482,295
Noncurrent Assets
Operating lease, right-of-use asset9480
Property, plant and equipment1,3951,060868680580483443
Long-term investments and receivables802586506567532384247
Long-term investments802586506567532380241
Accounts and financing receivable, after allowance for credit loss     46
Intangible assets, net (including goodwill)1,5051,5041,4551,595831834399
Goodwill1,1731,1681,1121,127626628376
Intangible assets, net (excluding goodwill)33133734346820520523
Deferred income tax assets231172
Other noncurrent assets1201023410912313149
Deferred tax assets, net  20418192
Other undisclosed noncurrent assets  174214   
Total noncurrent assets:4,1463,5043,0373,1642,2702,0111,230
TOTAL ASSETS:7,2376,4885,3245,6964,5104,0593,524
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities562647496562410141140
Accounts payable197180134117976458
Accrued liabilities11011710498916373
Employee-related liabilities237296226249216  
Taxes payable195331986159
Debt 26 598   
Derivative instruments and hedges, liabilities396425343
Restructuring reserve151708 198
Estimated litigation liability382019715864
Business combination, contingent consideration, liability   52   
Deferred tax liabilities    8
Other undisclosed current liabilities241187180144111306272
Total current liabilities:8949028771,403533476434
Noncurrent Liabilities
Long-term debt and lease obligation668653594438822600598
Long-term debt, excluding current maturities595594594438822600598
Operating lease, liability7359
Liabilities, other than long-term debt886548454504536480300
Liability for uncertainty in income taxes214172125165230195195
Estimated litigation liability233      
Other liabilities252203150147306285106
Business combination, contingent consideration, liability186173179193   
Total noncurrent liabilities:1,5541,2011,0479431,3591,080899
Total liabilities:2,4482,1031,9242,3461,8911,5561,333
Stockholders' equity
Stockholders' equity attributable to parent4,5744,1483,1402,9562,6192,5032,191
Common stock636218215212243239129
Treasury stock, value(1,904)(1,279)(1,015)(252)(2,499)(1,837)(1,557)
Additional paid in capital1,4381,6231,3841,1671,168947878
Accumulated other comprehensive loss(161)(156)(139)(133)(198)(183)(101)
Retained earnings4,5653,7422,6951,9623,9063,3372,842
Total stockholders' equity:4,5744,1483,1402,9562,6192,5032,191
Other undisclosed liabilities and equity215237259394   
TOTAL LIABILITIES AND EQUITY:7,2376,4885,3245,6964,5104,0593,524

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues4,3864,3483,7233,4352,9642,4942,323
Revenue, net3,4352,9642,4942,323
Cost of revenue(1,081)(1,114)(939)(875)(797)(617)(630)
Cost of goods and services sold(1,081)(1,114)(939)(875)(797)(617)(626)
Other undisclosed gross profit      4
Gross profit:3,3063,2342,7832,5602,1661,8771,697
Operating expenses(2,395)(2,028)(1,925)(1,464)(1,381)(1,234)(1,209)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
 (65)(116)(60)(35) (71)
Other undisclosed operating income (loss)(14)66    
Operating income:8981,1477481,036751643417
Nonoperating income35403612633
Investment income, nonoperating233232201186
Loss on contract termination      (1)
Foreign currency transaction loss, before tax     (5)(2)
Other nonoperating income (expense)1284(8)(5)  
Interest and debt expense(16)(21)(30)(23)(19)(17)(17)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  710 (6)740
Income from continuing operations before income taxes:9171,1677611,0357386221,144
Income tax expense(93)(120)(39)(451)(168)(128)(333)
Net income available to common stockholders, diluted:8231,047722584570495811

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:8231,047722584570495811
Other comprehensive income (loss)  (16)32  (6)
Comprehensive income:8231,047706616570495806
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(5)(18)1834(16)(82)(68)
Comprehensive income, net of tax, attributable to parent:8181,029724649554413738

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: